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ABSTRACT 
Insulin resistance and type 2 diabetes (T2D) are associated with an 
increased prevalence of atherosclerotic cardiovascular disease (CVD). A key 
step in the initiation of atherogenesis is retention of low density lipoproteins 
(LDL) in the intima by chondroitin sulfate (CS)-rich proteoglycans (PG). In 
addition, heparan sulfate (HS)-containing PGs in liver have a major 
physiological function in the retention and internalization of chylomicron and 
very low density lipoprotein (VLDL) remnant particles. Elevated levels of 
circulating non-esterified fatty acids (NEFA) are part of the dyslipidemia of 
insulin resistance and T2D. The objective of this thesis was to investigate the 
impact of chronic NEFA elevation on extracellular matrix (ECM) PGs and its 
implications for diabetes-associated CVD. 
Linoleate incubation decreased the PG secretion and gene expression of the 
core proteins of versican, and to a lesser extent, syndecan-1, in the human 
liver-derived cell line HepG2. The GAG chains of secreted PGs had a lower CS 
content. PGs extracted from livers of the insulin-resistant hyperlipidemic 
Zucker fa/fa rat carried GAG chains with increased CS content at the expense 
of HS compared with livers from their lean littermates. These changes resulted 
in a reduced capacity to bind β-VLDL remnant particles. Incubation of primary 
cultures of human arterial smooth muscle cells with linoleate or palmitate 
increased the gene expression of the core proteins of versican, biglycan, 
perlecan and decorin; and of CS synthase, CS-6 and CS-4 sulfotransferases, 
key enzymes for the polymerization and sulfation of chondroitin chains. These 
effects were accompanied by increased PG secretion. Secreted PGs were 
enriched in chondroitin/dermatan sulfate and with a higher extent of sulfation, 
resulting in a more efficient binding of LDL compared with PGs from control 
cells. Investigation of the signaling pathways involved in the linoleate-induced 
increase of versican expression showed that it was mediated by an 
extracellular signal-regulated kinase (ERK)-dependent activation of the 
transcription factor CCAAT-enhancer binding protein (C/EBP)β. These findings 
suggest a novel role for C/EBPβ in the fatty acid-induced changes of ECM. 
Chronic NEFA elevation resulted in changes in the properties of matrix PGs 
that may contribute to generate a remnant-rich dyslipidemia and to pre-
condition the arterial intima for lipoprotein deposition. Therefore, 
normalization of the fatty acid homeostasis should be considered a key target 
in the treatment of the atherogenic dyslipidemia of insulin resistance. 
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